Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2008-06-10
2008-06-10
Yu, Misook (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C435S810000
Reexamination Certificate
active
07385035
ABSTRACT:
This invention relates to a new cytotoxic protein (M toxin, mucous layer devastating toxin) produced byHelicobacter pyloriand the use.This invention provides a cytotoxic protein (M toxin) produced byHelicobacter pylori, a partial peptide, and an antitumor agent containing the cytotoxic protein. The protein is obtained by culturing a transformant which is transformed with a recombination vector containing DNA coding the cytotoxin protein. This invention provides further the use of the protein.
REFERENCES:
patent: 4800155 (1989-01-01), Taniguchi et al.
patent: 5024946 (1991-06-01), Abe et al.
patent: 5093261 (1992-03-01), Hagiwara et al.
patent: 5366865 (1994-11-01), Gralnick
patent: 5776427 (1998-07-01), Thorpe et al.
patent: 5863538 (1999-01-01), Thorpe et al.
patent: 5877289 (1999-03-01), Thorpe et al.
patent: 6004555 (1999-12-01), Thorpe et al.
patent: 6093399 (2000-07-01), Thorpe et al.
patent: 6417337 (2002-07-01), Anderson et al.
patent: 6753420 (2004-06-01), Anderson et al.
patent: 6787153 (2004-09-01), Hosokawa et al.
patent: 6887474 (2005-05-01), Stewart et al.
patent: 2002/0061569 (2002-05-01), Haselbeck et al.
patent: WO 97/37044 (1997-10-01), None
U.S. Appl. No. 11/049,118, filed Oct. 2005, Awdalla.
U.S. Appl. No. 11/149,515, filed Dec. 2005, Nichols et al.
U.S. Appl. No. 11/205,045, filed Dec. 2005, Stewart et al.
Brown, J. M. “Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies.” Molecular Medicine Today Apr. 2000 (vol. 6).
Paganelli G, Riva P, Deleide G, et al,In vivo labelling of biotinylated monoclonal antibodies by radioactive avidin: a strategy to increase tumor radiolocalization, Int J Cancer Suppl. 1988; 2: 121-125.
P. Webber et al., “Structural origins of high-affinity biotin binding to streptavidin” Science, vol. 243, pp. 85-88, Jan. 6, 1989.
M. Wilchek et al, The avidin-biotin complex in bioanalytical applications Analytical Biochemistry, vol. 171 pp. 1-32, 1988.
Bayer et al., “The Avidin-Biotin Complex as a Tool in Molecular Biology”, Trends in Biochemical Science, 3, N257, Nov. 1978.
Otto C. Boerman et al., “Pretargeted Radioimmunotherapy of Cancer: Progress Step by Step”, Journal of Nuclear Medicine vol. 44 No. 3 400-411.
Kohler and Milstein, Nature, 256: 495-97, 1975; Eur. J. Immunol., 6: 511-19, 1976.
Hechler, B., Leon, C., Vial, C., Vigne, P., Frelin, C., Cazenave, J. P., and Gachet, C. (1998) Blood 92, 152-159.
Duijvestijn et al., “Lymphoid Tissue- and Inflammation-Specific Endothelial Cell Differentiation defined by Monoclonal Antibodies,” The Journal of Immunology, 138(3):713-719, 1987.
Hagemeier et al., “A Monoclonal Antibody Reacting with Endothelial Cells of Budding Vessels in Tumors and Inflammatory Tissues, and Non-Reactive with Normal Adult Tissues,” International Journal of Cancer, 38:481-488, 1986.
Bruland et al., “New Monoclonal Antibodies Specific for Human Sarcomas,” International Journal of Cancer, 38:27-31, 1986.
Murray et al., “Vascular Markers for Murine Tumours,” Radiotherapy and Oncology, 16:221-234, 1989.
Schlingemann et al., “Monoclonal Antibody PAL-E Specific for Endothelium,” Laboratory Investigation, 52(1):71-76, 1985.
Shrestha et. al., Eur. J. Cancer B. Oral. Oncol., 30B(6):393-9, 1994.
Tuominen and Kallioinen, J. Cutan. Pathol. 21(5):424-9, 1994.
American Cancer Society: Cancer Facts and Figures 2005.
Ohno Hiroyuki
Saisho Hiromitsu
Tanzawa Hideki
Browdy and Neimark PLLC
Fourier Inc.
Halvorson Mark
Yu Misook
LandOfFree
Cytotoxic protein and utilization thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytotoxic protein and utilization thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic protein and utilization thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2814771